Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm

被引:166
作者
Achar, Suraj [1 ]
Rostamian, Armand [1 ]
Narayan, Sanjiv M. [1 ]
机构
[1] Univ Calif San Diego, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
ACUTE MYOCARDIAL-INFARCTION; BODY-BUILDERS; WEIGHT-LIFTERS; MALE BODYBUILDERS; TISSUE DOPPLER; ATHLETES HEART; GROWTH-HORMONE; LIVER-FUNCTION; UNITED-STATES; SUDDEN-DEATH;
D O I
10.1016/j.amjcard.2010.05.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent surveys and reports suggest that many athletes and bodybuilders abuse anabolic-androgenic steroids (AAS). However, scientific data on the cardiac and metabolic complications of AAS abuse are divergent and often conflicting. A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. Although studies were typically small and retrospective, some associated AAS abuse with unfavorable effects. Otherwise healthy young athletes abusing AAS may show elevated levels of low-density lipoprotein and low levels of high-density lipoprotein. Although data are conflicting, AAS have also been linked with elevated systolic and diastolic blood pressure and with left ventricular hypertrophy that may persist after AAS cessation. Finally, in small case studies, AAS abuse has been linked with acute myocardial infarction and fatal ventricular arrhythmias. In conclusion, recognition of these adverse effects may improve the education of athletes and increase vigilance when evaluating young athletes with cardiovascular abnormalities. (C) 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010; 106:893-901)
引用
收藏
页码:893 / 901
页数:9
相关论文
共 101 条
  • [1] Cardiac arrest following anaesthetic induction in a world-class bodybuilder
    Angelilli, A
    Katz, ES
    Goldenberg, RM
    [J]. ACTA CARDIOLOGICA, 2005, 60 (04) : 443 - 444
  • [2] [Anonymous], 1996, Journal of Performance Enhancing Drugs
  • [3] Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: Analysis of serum and urine samples in healthy men
    Bagchus, WM
    Smeets, JMW
    Verheul, HAM
    De Jager-Van der Veen, SM
    Port, A
    Geurts, TBP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) : 2624 - 2630
  • [4] LIPID AND APOPROTEIN MODIFICATIONS IN BODY BUILDERS DURING AND AFTER SELF-ADMINISTRATION OF ANABOLIC-STEROIDS
    BALDOENZI, G
    GIADA, F
    ZULIANI, G
    BARONI, L
    VITALE, E
    ENZI, G
    MAGNANINI, P
    FELLIN, R
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (02): : 203 - 208
  • [5] Anabolic-androgenic steroid therapy in the treatment of chronic diseases
    Basaria, S
    Wahlstrom, JT
    Dobs, AS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) : 5108 - 5117
  • [6] BERGINK EW, 1985, ACTA ENDOCRINOL-COP, V110, P31
  • [7] ANABOLIC-STEROIDS AND INFARCTION
    BOWMAN, S
    [J]. BRITISH MEDICAL JOURNAL, 1990, 300 (6726) : 750 - 750
  • [8] Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study
    Chung, T.
    Kelleher, S.
    Liu, P. Y.
    Conway, A. J.
    Kritharides, L.
    Handelsman, D. J.
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 66 (02) : 235 - 245
  • [9] Behavioral and physiological responses to anabolic-androgenic steroids
    Clark, AS
    Henderson, LP
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (05) : 413 - 436
  • [10] PHYSIOLOGICAL HYPERTROPHY - EFFECTS ON LEFT-VENTRICULAR SYSTOLIC MECHANICS IN ATHLETES
    COLAN, SD
    SANDERS, SP
    BOROW, KM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (04) : 776 - 783